Literature DB >> 18037354

Fusion and nonsurgical treatment for symptomatic lumbar degenerative disease: a systematic review of Oswestry Disability Index and MOS Short Form-36 outcomes.

Leah Y Carreon1, Steven D Glassman, Jennifer Howard.   

Abstract

BACKGROUND CONTEXT: Although numerous studies have been published, controversy still exists regarding fusion and nonsurgical treatment for symptomatic degenerative lumbar spine conditions. Definite conclusions are difficult to draw because of differences in patient inclusion criteria, fusion technique, nonoperative treatment regimen, and clinical outcome measures used to determine success.
PURPOSE: The objective of this study was to evaluate lumbar fusion and nonsurgical interventions for various degenerative spine disorders using the Oswestry Disability Index (ODI) as a primary outcome measure in a systematic review. A secondary objective was to determine whether there is a difference in clinical outcomes based on the specific diagnosis. STUDY DESIGN/
SETTING: Systematic review. PATIENT SAMPLE: Patients with low back pain of at least 12 weeks duration and older than 18 years, with prospectively collected ODI scores and at least a 12-month follow-up. OUTCOME MEASURES: ODI and Short Form-36 (SF-36).
METHODS: A MEDLINE, HealthSTAR, CINAHL, and Cochrane database search was done using the search strategy recommended by the Cochrane Back Review Group. Proceedings from annual meetings of various spine societies and reference lists from review articles and retrieved articles were evaluated for possible inclusion. Criteria for inclusion were prospective randomized clinical trials in patients with low back pain of at least 12 weeks duration and older than 18 years; with prospectively collected ODI scores and at least a 12-month follow-up. The methodological quality of the studies was assessed using the van Tulder criteria. Data extracted from each study included demographics, study design, diagnosis, baseline and change in ODI, and baseline and change in SF-36 Physical Composite Score (PCS). The data were pooled and analyzed based on the primary reported inclusion diagnosis: degenerative disc disease (DDD), chronic low back pain (CLBP), and spondylolisthesis; and treatment: fusion (unspecified, posterior, anterior, combined) and nonsurgical.
RESULTS: Twenty-five studies met the inclusion criteria. The distribution of sex and smokers was similar across diagnoses and treatments. Patients with spondylolisthesis were older than patients with DDD and CLBP. Patients with spondylolisthesis had the greatest ODI improvement followed by patients with DDD and CLBP. The three fusion types produced similar amounts of improvement in ODI. Nonsurgical patients did not improve as much but had a lower baseline ODI. Improvements in the SF-36 PCS were fairly consistent across diagnostic groups and treatment types.
CONCLUSIONS: Substantial improvement can be expected in patients treated with fusion, regardless of technique, when an established indication such as spondylolisthesis or DDD exists. CLBP patients are less disabled and experience less improvement.

Entities:  

Mesh:

Year:  2007        PMID: 18037354     DOI: 10.1016/j.spinee.2007.06.013

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.166


  40 in total

1.  Interspinous implant with unilateral laminotomy for bilateral decompression of degenerative lumbar spinal stenosis in elderly patients.

Authors:  Sung-Joo Ryu; In-Soo Kim
Journal:  J Korean Neurosurg Soc       Date:  2010-05-31

2.  Correlation of clinical outcome and spinopelvic sagittal alignment after surgical treatment of low-grade isthmic spondylolisthesis.

Authors:  A Bourghli; S Aunoble; O Reebye; J C Le Huec
Journal:  Eur Spine J       Date:  2011-08-02       Impact factor: 3.134

3.  Is Osteogenic Differentiation of Human Nucleus Pulposus Cells a Possibility for Biological Spinal Fusion?

Authors:  Sharon J Brown; Sarah A Turner; Birender S Balain; Neil T Davidson; Sally Roberts
Journal:  Cartilage       Date:  2018-01-23       Impact factor: 4.634

Review 4.  Minimally invasive techniques for lumbar decompressions and fusions.

Authors:  Ankur S Narain; Fady Y Hijji; Jonathan S Markowitz; Krishna T Kudaravalli; Kelly H Yom; Kern Singh
Journal:  Curr Rev Musculoskelet Med       Date:  2017-12

5.  [Symptomatic lumbar spinal stenosis: diagnostic evaluation and therapeutic strategies].

Authors:  C Ewald; R Kalff
Journal:  Nervenarzt       Date:  2011-12       Impact factor: 1.214

Review 6.  Lumbar spinal stenosis: who should be fused? An updated review.

Authors:  Farzad Omidi-Kashani; Ebrahim Ghayem Hasankhani; Amir Ashjazadeh
Journal:  Asian Spine J       Date:  2014-08-19

7.  Treatment of painful Modic type I changes by vertebral augmentation with bioactive resorbable bone cement.

Authors:  Salvatore Masala; Giovanni Carlo Anselmetti; Stefano Marcia; Giovanni Nano; Amedeo Taglieri; Eros Calabria; Marcello Chiocchi; Giovanni Simonetti
Journal:  Neuroradiology       Date:  2014-05-01       Impact factor: 2.804

8.  Comparison of pure lateral and oblique lateral inter-body fusion for treatment of lumbar degenerative disk disease: a multicentric cohort study.

Authors:  Massimo Miscusi; Alessandro Ramieri; Stefano Forcato; Mary Giuffrè; Sokol Trungu; Marco Cimatti; Alessandro Pesce; Pietro Familiari; Amedeo Piazza; Cristina Carnevali; Giuseppe Costanzo; Antonino Raco
Journal:  Eur Spine J       Date:  2018-04-18       Impact factor: 3.134

9.  Psychological predictors of quality of life and functional outcome in patients undergoing elective surgery for degenerative lumbar spine disease.

Authors:  Arthur Wagner; Youssef Shiban; Corinna Wagner; Kaywan Aftahy; Ann-Kathrin Joerger; Bernhard Meyer; Ehab Shiban
Journal:  Eur Spine J       Date:  2019-08-14       Impact factor: 3.134

10.  Magnetic resonance spectroscopy (MRS) can identify painful lumbar discs and may facilitate improved clinical outcomes of lumbar surgeries for discogenic pain.

Authors:  Matthew G Gornet; James Peacock; John Claude; Francine W Schranck; Anne G Copay; Robert K Eastlack; Ryan Benz; Adam Olshen; Jeffrey C Lotz
Journal:  Eur Spine J       Date:  2019-01-04       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.